PeptideDB

Idelalisib D5

CAS No.: 1830330-31-8

Idelalisib D5, a version of Idelalisib marked with deuterium, is an orally bioavailable and highly selective inhibitor o
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Idelalisib D5, a version of Idelalisib marked with deuterium, is an orally bioavailable and highly selective inhibitor of p110δ.
Synonyms CAL-101 D5, GS-1101 D5
molecular weight 420.45
Molecular formula C22H18FN7O
CAS 1830330-31-8
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
References 1. Lannutti BJ, et al. CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood, 2011, 117(2), 591-594.